Creoptix launches new WAVEcontrol software to deliver automated, flexible and intuitive label-free interaction analysis for biologics drug-discovery

Creoptix® (a Malvern Panalytical brand) is announcing the addition of two new wizards to their WAVEcontrol software to simplify and streamline workflows. By combining the high sensitivity, throughput, and no-clog microfluidics of the WAVEsystem, with a faster, more flexible, automated approach to screening and characterization, Creoptix is accelerating biologics drug discovery and diagnostics development.

Related Keywords

Malvern Panalytical ,Malvern Panalyticalsep ,Tatiana Tiago , ,From Malvern Panalyticalsep ,Direct Kinetics ,Ligand Block ,Target Level ,Product Manager ,Global Access Diagnostics ,Analyte ,Iagnostics ,Drug Discovery ,Migand ,Microfluidics ,Protein ,